Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors,and Heads of departments from pharmaceutical industry involved in:
Computational Biology and Chemistry
High Throughput Screening
Early research and development
R&D Information Technology
In vivo, In vitro, In silico
PAST CASE STUDIES INCLUDE
CASE STUDY / DAY 1
Current achievement and (near-)future promise of AI in drug discovery
While AI currently seems at the top of its hype cycle, it is sometimes overlooked that certain AI techniques already deliver everyday benefit in drug discovery. At Merck, there are more than 270 Deep Learning-based predictive models in place, which help the medicinal chemists in the selection of the right molecules to synthesise. In order to make such models used, they must be served in very convenient and easy-to-interpret ways, which we achieve through a custom-built environment. A current shortcoming is that most models are still giving binary (or three-class) predictions (active/inactive or active/intermediate/inactive), and do not give immediate directions on how to modify a given molecules in order to achieve the desired activity. Extracting this information from Deep Networks and conveniently mapping it to molecular structure is an area of active research, and progress on this will be highlighted. Another area where predictive models can be used productively is the area of automatic data quality improvement. New property measurements of molecules can be compared versus the respective predictions and, if there is a significant deviation, can be measured again. We observed that this allows us to capture errors and thus improve data quality, which then improves model quality – the virtuous cycle of data quality. The next big area of progress will be the automatic “invention” of molecules with desired properties, including ease of synthesis. And there is way more to come.
More than 270 Deep Learning-based predictive models deliver benefit to drug discovery at Merck
Focus of current research is on interpretability of predictions and on directions for what molecule to make next
Automatic invention of molecules with desired activities, including ease of synthesis, becomes a reality
Director, Global Computational Chemistry & Biology
Chief Data Officer R&D
CASE STUDY / DAY 1
Current challenges in R&D Data management
The aim of the presentation is to show what challenges we have to face in R&D data management and how we address them. Various successful use cases experienced at Servier will be shown.
Master data management in R&D
Data privacy vs. data sharing
CASE STUDY / DAY 2
Machine-Learning Models for Predicting Frequent Hitter Behavior of Small Molecules
Assay interference caused by small molecules continues to pose significant challenges for early drug discovery. These compounds are typically aggregators, reactive compounds and/or pan-assay interference compounds (PAINS), and many of them are frequent hitters. This presentation will start with a brief overview of computer-aided methods aiming at the identification of different types of undesired and potentially problematic compounds. I will then focus on new machine-learning models developed in our laboratory that allow the accurate identification of frequent hitters. The models are accessible via a free web service (“Hit Dexter 2.0”) and as a software package for offline use.
Assay interference caused by small molecules continues to pose significant challenges for early drug discovery
The scope and reach of available in silico methods to predict such compounds is limited
We present a new machine learning approach that allows the identification of frequent hitters with high accuracy
The models are accessible via a free web service (“Hit Dexter 2.0”) and as a software package for offline use
Associate Professor in Bioinformatics
Haytham Mohamed YOUSRI
Director of Human Resources
CASE STUDY / DAY 2
Local Talent Opportunities and Cost
The real cost of hiring a local in GCC region in comparison with hiring an expat is still not discovered. I will focus on the hidden savings for hiring a local talent and the benefits which can attract them without increasing your cost.
STAY UPDATED FOR THE 2020 EDITION
Provide us with your contact details and our team will get back to you with all the updates regarding the upcoming edition of this event.